NYSE: LAC
LITHIUM AMERICAS CORP.CIK 0001966983 · SIC 1000 · Metal Mining
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (PANW 10-K) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade LAC commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-Q filed Aug 13, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Statements of Income (Loss) (Unaudited)
(Expressed in thousands of U.S. dollars, except for per share amounts and shares in thousands)
| Description | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Operating expenses | ||||
| Exploration expenditures | - | - | - | (19) |
| General and administrative expenses (Note 11) | (15,139) | (7,848) | (26,236) | (14,365) |
| Total operating expenses | (15,139) | (7,848) | (26,236) | (14,384) |
| Other income (expense) | ||||
| Transaction costs (Note 12) | - | (13,337) | (1,001) | (17,639) |
| Gain/(loss) on financial instruments measured at fair value: | ||||
| Gain on LAC Warrant and JV Warrant obligations (Note 4) | 4,469 | - | 4,886 | - |
| Gain on convertible debt and conversion feature (Note 8) | 5,704 | 6,762 | 20,008 | 6,762 |
| Loss on investments measured at fair value | (82) | (245) | (4,689) | (2,201) |
| Other income | 6,710 | 1,419 | 13,322 | 2,687 |
| Total other income (expense) | 16,801 | (5,401) | 32,526 | (10,391) |
| Net income (loss) | 1,662 | (13,249) | 6,290 | (24,775) |
| Net income (loss) attributable to: | ||||
| Common stockholders | 2,151 | (12,447) | 1,742 | (23,149) |
| Non-controlling interest | (489) | (802) | 4,548 | (1,626) |
| Total | 1,662 | (13,249) | 6,290 | (24,775) |
| Net income (loss) per share attributable to common stockholders, basic (Note 10) | 0.01 | (0.06) | 0.00 | (0.11) |
| Net income (loss) per share attributable to common stockholders, diluted (Note 10) | (0.02) | (0.06) | (0.07) | (0.11) |
| Weighted average number of common shares outstanding, basic | 371,790 | 219,581 | 362,534 | 219,092 |
| Weighted average number of common shares outstanding, diluted | 401,738 | 219,581 | 391,761 | 219,092 |
Balance Sheets (Unaudited)
(Expressed in thousands of U.S. dollars, except for shares in thousands)
| Description | June 30, 2026 | December 31, 2025 |
|---|---|---|
| ASSETS | ||
| Cash (Note 2) | 822,782 | 568,226 |
| Restricted cash (Note 2) | 456,408 | 337,383 |
| Receivables | 2,208 | 4,110 |
| Prepaids and deposits | 1,055 | 1,920 |
| Total current assets | 1,282,453 | 911,639 |
| Investments measured at fair value (Note 14) | 174 | 4,863 |
| Mineral properties, plant and equipment, net (Note 3) | 2,090,756 | 1,344,004 |
| Deferred financing costs (Note 4) | 154,583 | 311,808 |
| Other assets | 7,933 | 6,734 |
| Total assets | 3,535,899 | 2,579,048 |
| LIABILITIES | ||
| Accounts payable | 101,327 | 87,848 |
| Accrued liabilities (Note 6) | 127,453 | 83,441 |
| Current portion of lease liabilities (Note 7) | 5,811 | 5,530 |
| Total current liabilities | 234,591 | 176,819 |
| Convertible debt and conversion feature (Note 8) | 147,701 | 160,017 |
| LAC Warrant obligation (Note 4) | - | 83,796 |
| JV Warrant obligation (Note 4) | 140,419 | 150,295 |
| DOE Loan (Note 4) | 988,018 | 350,987 |
| Royalty and production payment arrangements (Note 8) | 55,634 | 50,844 |
| Lease liabilities (Note 7) | 15,986 | 15,668 |
| Reclamation liabilities | 473 | 473 |
| Other liabilities | 3,500 | 3,500 |
| Total liabilities | 1,586,322 | 992,399 |
| Commitments (Note 15) | ||
| Non-controlling interest (Note 5) | 532,443 | 527,895 |
| STOCKHOLDERS’ EQUITY | ||
| Common stock, no par value, unlimited authorized; 361,841 and 314,335 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively (Note 9) | 1,551,761 | 1,279,902 |
| Additional paid-in capital | 84,779 | - |
| Accumulated deficit | (219,406) | (221,148) |
| Total stockholders’ equity | 1,417,134 | 1,058,754 |
| Total liabilities, non-controlling interest and stockholders’ equity | 3,535,899 | 2,579,048 |
Statements of Cash Flows (Unaudited)
(Expressed in thousands of U.S. dollars)
| Description | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|
| Operating activities | ||
| Net income (loss) | 6,290 | (24,775) |
| Adjustments for: | ||
| Depreciation | 30 | 22 |
| Stock-based compensation | 4,122 | 2,652 |
| Amortization of right-of-use asset | 533 | 512 |
| Loss/(gain) on financial instruments measured at fair value: | ||
| Gain on LAC Warrant and JV Warrant obligations (Note 4) | (4,886) | - |
| Gain on convertible debt and conversion feature (Note 8) | (20,008) | (6,762) |
| Loss on investments measured at fair value | 4,689 | 2,201 |
| Other items | - | 182 |
| Changes in operating assets and liabilities: | ||
| Increase in receivables | (47) | (20) |
| Decrease in prepaids and deposits | 534 | 854 |
| Increase/(decrease) in accounts payable | (13,664) | 253 |
| Decrease in accrued liabilities | (1,235) | (24,005) |
| Operating lease payments, net of non-cash interest accrual | (179) | (498) |
| Net cash used in operating activities | (23,821) | (49,384) |
| Investing activities | ||
| Additions to mineral properties, plant and equipment | (631,564) | (353,503) |
| Net cash used in investing activities | (631,564) | (353,503) |
| Financing activities | ||
| Proceeds from convertible debt and production payment arrangements, net of issuance and transaction costs (Note 8) | - | 211,754 |
| Proceeds from issuance of non-controlling interest (Note 5) | - | 100,000 |
| Proceeds from public offerings, net of issuance costs (Note 9) | 258,220 | 8,841 |
| Proceeds from DOE Loan (Note 4) | 774,000 | - |
| Payment of financing costs | (803) | (350) |
| Principal payments on finance lease obligations | (2,451) | (2,391) |
| Net cash provided by financing activities | 1,028,966 | 317,854 |
| Net increase (decrease) in cash and restricted cash | 373,581 | (85,033) |
| Cash and restricted cash, beginning of period (Note 2) 1 | 905,609 | 594,173 |
| Cash and restricted cash, end of period (Note 2) 1 | 1,279,190 | 509,140 |
Amounts as printed on the EDGAR/iXBRL face — (Expressed in thousands of U.S. dollars, except for per share amounts and shares in thousands); (Expressed in thousands of U.S. dollars, except for shares in thousands); (Expressed in thousands of U.S. dollars). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗